WNK2 and cardiac hypertrophy: We show here that sunitinib increases the Mitogen-Activated Protein Kinases (MAPK/ERK) pathway, a key player in myocardial hypertrophy 26, 27, in agreement with a previous report in isolated cardiomyocytes 28.